Providers/Grant Support
Jointly provided by Partners for Advancing Clinical Education (Partners) and DKBmed, LLC.
This activity is supported by an independent educational grant from Amgen, Inc.
Credits Available
- Physicians — maximum of 0.5 AMA PRA Category 1 Credits™
- Physician Assistants — 0.5 AAPA Category 1 CME credits
- Nurses — 0.5 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
The intended audience for this Infograph-ed activity will be primary care clinicians (MD, PA, NP, RN) and cardiologists.
Program Overview
New American Heart Association guidelines on lipoprotein(a) were just released! Lipoprotein(a) - also referred to as Lp(a) - is a causal, genetically determined risk factor for cardiovascular disease (CVD). Traditional CVD risk calculators often overlook Lp(a). This interactive infographic helps clinicians quickly understand:
• Who should be tested and why
• How Lp(a) refines CVD risk stratification
• Practical LP(a) management strategies available today
• What’s coming with Lp(a)-lowering therapies in late-stage development
Built for busy clinicians, this visual, interactive experience turns cutting-edge data into clear clinical insight. Start today!
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe recommendations for Lp(a) testing.
- Appraise treatment strategies for patients with elevated Lp(a).
- Discuss efficacy and safety of treatments that target elevated Lp(a).
Faculty
Michelle O’Donoghue, MD, MPH
McGillycuddy-Logue Endowed Chair in Cardiology
Associate Professor, Harvard Medical School
Cardiovascular Medicine
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and DKBmed LLC. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Education
Partners designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.
PA Continuing Medical Education
Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until March 2nd, 2027. PAs should only claim credit commensurate with the extent of their participation.
Disclosures of Conflicts of Interest
Dr. Michelle O’Donoghue
- Consultant, Advisor, Speaker: Medscape Cardiology, Amgen Novartis, Janssen AstraZeneca and CRICO
- Researcher: Amgen AstraZeneca Novarti, Merck, Janssen and Medicines Company
Instructions For Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
To access activities, users will need:
- A computer with an internet connection
- An HTML5 compliant web browser or Internet Explorer 8 (and higher)
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For additional information about the accreditation of this activity, please visit https://partnersed.com